Cargando…
Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach
OBJECTIVE: Multiple daily injections (MDI) therapy is the most common treatment for type 1 diabetes (T1D), consisting of long-acting insulin to cover fasting conditions and rapid-acting insulin to cover meals. Titration of long-acting insulin is needed to achieve satisfactory glycemia but is challen...
Autores principales: | El Fathi, Anas, Fabris, Chiara, Breton, Marc D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785345/ https://www.ncbi.nlm.nih.gov/pubmed/35082757 http://dx.doi.org/10.3389/fendo.2021.795895 |
Ejemplares similares
-
The Review of Insulin Pens—Past, Present, and Look to the Future
por: Masierek, Małgorzata, et al.
Publicado: (2022) -
Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution
por: Fabris, Chiara, et al.
Publicado: (2019) -
InPen Smart Insulin Pen System: Product Review and User Experience
por: Gildon, Bradford W.
Publicado: (2018) -
ARHGAP21 Acts as an Inhibitor of the Glucose-Stimulated Insulin Secretion Process
por: Ferreira, Sandra M., et al.
Publicado: (2020) -
Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems
por: Wang, Huiying, et al.
Publicado: (2022)